Table 2.
Five- and ten-year relative survival ratio by selected risk factors and waiting time cut-offs, prostate cancer with curative surgery, 1996-2009
| Variable |
Five-year survival |
Ten-year survival |
||||||
|---|---|---|---|---|---|---|---|---|
|
0-3 months waiting time |
4-6 months waiting time |
0-3 months waiting time |
4-6 months waiting time |
|||||
| Relative survival | 95% confidence interval | Relative survival | 95% confidence interval | Relative survival | 95% confidence interval | Relative survival | 95% confidence interval | |
|
Overall |
1.04 |
1.03 to 1.04 |
1.05 |
1.04 to 1.05 |
1.07 |
1.05 to 1.09 |
1.08 |
1.06 to 1.10 |
|
Age group | ||||||||
| 15-54 |
0.99 |
0.98 to 1.01 |
1.01 |
0.99 to 1.01 |
0.99 |
0.95 to 1.02 |
1.00 |
0.93 to 1.03 |
| 55-64 |
1.02 |
1.02 to 1.03 |
1.03 |
1.02 to 1.04 |
1.03 |
1.00 to 1.06 |
1.06 |
1.03 to 1.08 |
| 65 and above |
1.07 |
1.06 to 1.08 |
1.09 |
1.08 to 1.10 |
1.18 |
1.13 to 1.22 |
1.15 |
1.10 to 1.19 |
|
Region of Residence | ||||||||
| London |
1.04 |
1.02 to 1.06 |
1.06 |
1.04 to 1.07 |
1.10 |
1.04 to 1.14 |
1.03 |
0.95 to 1.10 |
| North East |
1.03 |
0.99 to 1.06 |
1.06 |
1.04 to 1.07 |
1.13 |
0.99 to 1.19 |
1.12 |
1.01 to 1.17 |
| North West |
1.04 |
1.00 to 1.06 |
1.05 |
1.02 to 1.08 |
1.13 |
1.01 to 1.20 |
1.10 |
0.87 to 1.21 |
| Yorkshire and the Humber |
1.05 |
1.02 to 1.06 |
1.06 |
1.04 to 1.07 |
1.02 |
0.89 to 1.10 |
1.05 |
0.98 to 1.11 |
| East Midlands |
1.05 |
1.02 to 1.06 |
1.04 |
1.00 to 1.06 |
1.10 |
0.99 to 1.15 |
1.13 |
1.07 to 1.17 |
| West Midlands |
1.04 |
1.01 to 1.06 |
1.06 |
1.04 to 1.07 |
1.13 |
1.05 to 1.18 |
1.10 |
1.02 to 1.15 |
| East of England |
1.03 |
1.00 to 1.04 |
1.02 |
1.00 to 1.04 |
1.01 |
0.94 to 1.07 |
1.06 |
1.00 to 1.11 |
| South East |
1.03 |
1.02 to 1.04 |
1.05 |
1.03 to 1.06 |
1.04 |
0.97 to 1.09 |
1.10 |
1.06 to 1.14 |
| South West |
1.03 |
1.01 to 1.04 |
1.05 |
1.03 to 1.06 |
1.10 |
1.05 to 1.14 |
1.10 |
1.04 to 1.14 |
|
Ethnicity
1
| ||||||||
| White |
1.04 |
1.02 to 1.05 |
1.06 |
1.04 to 1.07 |
|
|
|
|
| Non-White |
1.08 |
1.04 to 1.09 |
1.07 |
1.02 to 1.08 |
|
|
|
|
| Unknown |
1.06 |
1.05 to 1.07 |
1.07 |
1.05 to 1.07 |
|
|
|
|
|
Tumour differentiation | ||||||||
| Well differentiated |
1.04 |
1.01 to 1.06 |
1.05 |
1.03 to 1.07 |
1.12 |
1.06 to 1.16 |
1.12 |
1.07 to 1.16 |
| Moderately differentiated |
1.04 |
1.02 to 1.05 |
1.05 |
1.04 to 1.06 |
1.10 |
1.06 to 1.13 |
1.09 |
1.05 to 1.12 |
| Poor- & undifferentiated |
0.98 |
0.94 to 1.01 |
1.00 |
0.96 to 1.03 |
0.95 |
0.83 to 1.04 |
0.95 |
0.82 to 1.04 |
| Unknown |
1.04 |
1.03 to 1.05 |
1.05 |
1.05 to 1.06 |
1.06 |
1.02 to 1.09 |
1.09 |
1.05 to 1.12 |
|
Deprivation quintile | ||||||||
| 1 – least deprived |
1.04 |
1.03 to 1.05 |
1.05 |
1.04 to 1.06 |
1.07 |
1.00 to 1.12 |
1.10 |
1.04 to 1.14 |
| 2 |
1.04 |
1.03 to 1.05 |
1.05 |
1.04 to 1.06 |
1.10 |
1.04 to 1.14 |
1.12 |
1.07 to 1.15 |
| 3 |
1.03 |
1.01 to 1.04 |
1.04 |
1.03 to 1.05 |
1.05 |
0.97 to 1.11 |
1.04 |
0.97 to 1.09 |
| 4 |
1.04 |
1.02 to 1.05 |
1.05 |
1.04 to 1.06 |
1.10 |
1.04 to 1.15 |
1.09 |
1.02 to 1.13 |
| 5 – most deprived |
1.03 |
1.00 to 1.05 |
1.06 |
1.04 to 1.07 |
1.02 |
0.88 to 1.10 |
1.12 |
1.06 to 1.16 |
| Unknown |
1.01 |
0.97 to 1.04 |
1.04 |
1.00 to 1.07 |
1.04 |
0.97 to 1.09 |
1.06 |
0.99 to 1.11 |
|
Cancer plan implementation period | ||||||||
| Prior to implementation (1996–2000) |
1.03 |
1.00 to 1.04 |
1.04 |
1.02 to 1.05 |
1.05 |
1.02 to 1.08 |
1.06 |
1.03 to 1.09 |
| After implementation (2001–2009) | 1.04 | 1.03 to 1.04 | 1.05 | 1.05 to 1.06 | 1.08* | 1.05 to 1.11 | 1.11* | 1.09 to 1.12 |
*represents 9-year survival.
1all codes prior to 2005 were recoded as unknown; represents only data from 2005–2009.